Molecular hydrogen for outpatients with Covid-19 (Hydro-Covid): a phase 3, randomised, triple-blinded, adaptive, placebo-controlled, multicentre trial
Gaboreau Y, Milovančev A, Rolland C, Eychenne C, Alcaraz J, Ihl C, Mazet R, Boucher F, Vermorel C, Ostojic SM, Borel JC, Cinquin P, Bosson J · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
One death was reported in the H₂ group and 2 in the placebo group at day-30.
What the Researchers Studied
The study examined 2 patients.
How Molecular Hydrogen Was Used
Due to its antioxidative, anti-inflammatory, anti-apoptosis, and antifatigue properties, molecular hydrogen (H₂ ) is potentially a novel therapeutic gas for acute coronavirus disease 2019 (COVID-19) patients.
What the Researchers Found
Due to its antioxidative, anti-inflammatory, anti-apoptosis, and antifatigue properties, molecular hydrogen (H₂ ) is potentially a novel therapeutic gas for acute coronavirus disease 2019 (COVID-19) patients. How this fits in Only a few molecules specially developed against SARS-CoV-2 can limit impact of COVID-19 (vaccines, monoclonal antibodies or antiviral drugs) Using their multiple properties, H₂ may play a key role in preventing the severe and post-acute forms of COVID-19 Taking twice daily Hydrogen Rich Water (HRW) was not efficacious to prevent severe COVID-19 in at risk COVID-19 patients.
H₂ Mechanisms / Biological Findings
Due to its antioxidative, anti-inflammatory, anti-apoptosis, and antifatigue properties, molecular hydrogen (H₂ ) is potentially a novel therapeutic gas for acute coronavirus disease 2019 (COVID-19) patients.
Authors’ Conclusion
A distinct authors’ conclusion was not available in the source material reviewed by H2HUBB.